Jessica E (Ravikoff) Allegretti MD
Associate Director, Crohn’s and Colitis Center
Join to View Full Profile
75 Francis St# BrighamBoston, MA 02115
Phone+1 617-732-6389
Dr. Allegretti is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jessica Allegretti is a gastroenterologist in Boston, MA and is affiliated with Brigham and Women's Hospital. She received her medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 8 years. She is experienced in inflammatory bowel disease.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2012 - 2015
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
University of Miami Leonard M. Miller School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2011 - 2028
RI State Medical License 2022 - 2028
NH State Medical License 2022 - 2026
CT State Medical License 2022 - 2024
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Inflammatory Bowel Disease: Expert Review.Sahil Khanna, Jessica R Allegretti, Jana G Hashash, Paul Feuerstadt
Gastroenterology. 2026-07-01 - When Does Clostridioides difficile "Recur"? Reconcile Epidemiologic & Bedside Recurrent CDI definitions.Sahil Khanna, Paul Feuerstadt, Jessica R Allegretti, Darrell S Pardi
The Journal of Infectious Diseases. 2026-06-17 - Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.Gary R Lichtenstein, Jessica R Allegretti, David T Rubin, Fernando Magro, Brian Bressler
The American Journal of Gastroenterology. 2026-05-01
Press Mentions
Persistent Efficacy After Induction with SubQ Guselkumab in UCFebruary 9th, 2026- Microbiome Highlights from Digestive Disease Week 2025September 8th, 2025
- Fecal Therapy via Colonoscopy Found Safe and Effective for Recurrent C. DiffMay 4th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
